VCD, VD and VMP in front line treatment: Outcomes from Thai Myeloma Working Group – Patient Assistance Program (TMWG-PAP) von Lawasut, P, Khuhapinant, A, Wongkhantee, S, Wanitpongpun, C, Puavilai, T, Rattarittamrong, E, Suwanban, T, Kongkabpan, D, Numbenjapon, T, Deoisares, R, Nawarawong, W, Norasetthada, L, Nakorn, T.N

Volltext

Effect of high dose melphalan administration schedule: comparison between 1-day and 2-day dose for myeloma conditioning regimen von Lawasut, P, chanswangphuwana, C, Wudhikarn, K, Kijrattanakul, P, Chaiyapan, U, Polprasert, C, Uaprasert, N, Rojnuckarin, P, Intragumtornchai, T, Bunworasate, U, Nakorn, T.N

Volltext

Subgroup Analysis by Prior Treatment of the Efficacy and Safety of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myel... von Richardson, P.G, Hungria, V.T.M, Yoon, S.-S, Beksac, M, Dimopoulos, M.A, Elghandour, A, Jedrzejczak, W.W, Guenther, A, Nakorn, T.N, Siritanaratkul, N, Schlossman, R.L, Hou, J, Moreau, P, Lonial, S, Lee, J.H, Einsele, H, Sopala, M, Bengoudifa, B.R, Corrado, C, San-Miguel, J.F

Volltext

Impact of Treatment Duration and Dosing on Efficacy and Safety in a Phase 3 Study of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refrac... von San-Miguel, J.F, Hungria, V.T.M, Yoon, S.-S, Beksac, M, Dimopoulos, M.A, Elghandour, A, Jedrzejczak, W.W, Guenther, A, Nakorn, T.N, Siritanaratkul, N, Schlossman, R.L, Hou, J, Moreau, P, Lonial, S, Lee, J.H, Einsele, H, Sopala, M, Redhu, S, Paul, S, Corrado, C, Binlich, F, Richardson, P.G

Volltext

The RD-tree Allowing Data in Interior Nodes of the R-tree von Nakorn, T.N., Chongstitvatana, J.

Volltext